Rare diseases
Investigational molecules
Locations
Back to France1 537 clinical trials in Toulon, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of OMX-0407 for Patients with Previously Treated Unresectable Solid Tumors
FranceStudy on the Effects of Sparsentan and Irbesartan for Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)
FranceStudy on the Effects of Camlipixant in Adults with Refractory or Unexplained Chronic Cough
FranceStudy of Nivolumab for Children and Adults with Relapsed or Refractory ALK+ Anaplastic Large Cell Lymphoma
FranceStudy on Ceralasertib, Oleclumab, and Monalizumab for Advanced Non-Small Cell Lung Cancer Patients Resistant to PD-1 Inhibitors
FranceStudy on the Effect of Low-Dose Aspirin in Preventing New or Recurrent Colorectal Polyps in Patients with Lynch Syndrome
FranceStudy of Berubicin versus lomustine in adult patients with recurrent Glioblastoma Multiforme after first-line treatment failure
FranceStudy on the Effects of ARO-APOC3 for Adults with Familial Chylomicronemia Syndrome
FranceStudy of Vusolimogene Oderparepvec and Nivolumab for Patients with Solid Tumors
FranceStudy on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma
FranceStudy Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia
FranceStudy on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on non-small cell lung cancer treatments, including innovative combination therapies and immunotherapy approaches. Multiple studies evaluating novel drug combinations to improve patient outcomes.
Research spans various disease stages and includes both early-stage and metastatic cancer treatments.
Studies investigating treatments for chronic lymphocytic leukemia and blood-related conditions. Research includes evaluation of novel drug combinations and targeted therapies.
Focus on improving treatment outcomes for previously untreated patients with coexisting conditions.
Investigations into stroke prevention and treatment of thrombotic conditions. Studies evaluating new anticoagulants and therapeutic approaches for various cardiovascular conditions.
Clinical trials examining innovative treatments for atrial fibrillation and deep vein thrombosis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
